ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1377	National Cancer Institute	Html	en	Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for ovarian, fallopian tube, and primary peritoneal cancers.	ovarian cancer incidence 0.485939 PLCO trial participants 0.376238 annual CA-125 concentrations 0.379685 control group 0.373899 TVU 0.416096 intervention group 0.456353 ovarian cancer mortality 0.605058 usual-care group 0.519997 ovarian cancer. 0.438341 simultaneous screening 0.374743 multimodality screening 0.410213 ovarian cancer patients 0.493657 Ovarian Cancer Screening 0.521015 multimodality screening arm 0.400746 term ovarian cancer 0.514244 ovarian screening intervention 0.52207 Ovarian cancer diagnoses 0.474885 positive screening test 0.421138 ovarian cancer 0.995711 ovarian origin 0.452276 screening group 0.412155 PLCO trial 0.50373 screening centers 0.380449 Single-threshold CA-125 levels 0.385265	CA-125 reference value 0.384378 multimodal screening 0.42795 women 0.438262 screening test results 0.415787 low-grade serous carcinomas. 0.372717 ovarian cancers 0.495247 mortality rate ratio 0.417901 CA-125 concentrations 0.454756 screening protocol 0.374983 CA-125 levels 0.452675 incident ovarian cancers 0.460255 concurrent bulky carcinomas 0.374346 annual screening 0.391284 statistically nonsignificant mortality 0.377585 regular screening attendees 0.399753 ovarian volume increases 0.454792 high-grade serous carcinoma 0.426123 Shizuoka Cancer Registry 0.385833 epithelial ovarian carcinomas. 0.474733 cancer case treatment 0.383697 single-threshold CA-125 concentrations 0.37905 stage 0.375125 Elevated CA-125 levels 0.386511 Cancer Screening Trial 0.444611	CLICK HERE
1434	National Cancer Institute	Html	en	Chronic Lymphocytic Leukemia Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of chronic lymphocytic leukemia.	CLL 0.563454 German CLL Study 0.551069 monoclonal B-cell lymphocytosis 0.528403 Engl J Med 0.555252 trial 0.525679 leukemia group 0.552678 M. Prolymphocytic leukemia 0.545972 Routine chronic administration 0.534661 lymphocytic leukemia patients 0.591222 Leukemia group B. 0.542105 CLL Study Group 0.54078 cyclophosphamide 0.529502 Byrd JC 0.527428 Keating MJ 0.535835 advanced chronic 0.539233 patients 0.592663 Lymphocytic Leukemia Study 0.593872 T-cell prolymphocytic leukemia 0.546745 refractory high-risk chronic 0.534243 refractory chronic 0.528565 Adult Leukemia Group 0.542021 Leuk Lymphoma 0.531402 Lymphocytic Leukemia section 0.595648 fludarabine 0.547348 alemtuzumab versus fludarabine 0.527105	untreated B chronic 0.530625 et al. 0.648755 treatment 0.535273 small lymphocytic lymphoma 0.590269 French Cooperative Group 0.528743 German Chronic Lymphocytic 0.583925 Relapsed Chronic Lymphocytic 0.579501 acute myeloid leukemia 0.53754 stem cell 0.529413 Leukemia Study Group 0.55235 rituximab 0.530116 fludarabine-refractory B-cell chronic 0.53547 CLL therapy 0.52689 chronic lymphoid leukemia 0.573599 CLL Study Group. 0.526303 Abstract 0.627578 therapy 0.53011 Clin Oncol 0.713099 hairy cell leukemia 0.553353 blood 0.56117 chronic lymphocytic leukemia 0.965039 chronic lymphocytic leukaemia 0.705583 previously untreated patients 0.578343 allogeneic stem cell 0.525551	CLICK HERE
1584	National Cancer Institute	Html	en	Anal Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of anal cancer.	cancer treatment 0.433322 diagnose anal cancer 0.423593 Anal Cancer Treatment 0.419952 metastatic anal cancer 0.412176 Frequent anal redness 0.384126 body 0.434753 PDQ cancer information 0.446236 clinical trial search 0.504831 anal cancer spreads 0.410812 clinical trials 0.887836 cancer information summary 0.419039 clinical trial 0.647154 anus 0.449257 patients 0.429875 treatment clinical trial 0.380816 NCI PDQ cancer 0.384659 malignant tumor cells 0.380765 radiation therapy 0.718553 Treatment Editorial Board 0.382929 human immunodeficiency virus 0.375987 rectum 0.3805 General information 0.426863 general cancer information 0.376766 treatment 0.612453 abdominoperineal resection 0.403255	receptive anal intercourse 0.384527 new cancer treatments 0.377037 NCI-supported cancer 0.425485 cancer cells 0.46124 Cancer Information Service 0.376813 sphincter muscles 0.384557 treatment clinical trials 0.40741 National Cancer Institute 0.461854 Recurrent anal cancer 0.435676 new treatment 0.505194 external-beam radiation therapy 0.454262 IIIA anal cancer 0.402258 IIIB anal cancer 0.401297 anal cancer 0.792189 new treatment options 0.426789 anal opening 0.376839 cancer clinical trials 0.506964 stage 0.400723 Local resection 0.453758 tumor 0.401265 comprehensive cancer information 0.375327 internal radiation therapy 0.496063 cancer 0.970468 information 0.453326	CLICK HERE
1816	National Cancer Institute	Html	es	Tratamiento del glioma de tronco encefálico infantil (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del glioma de tronco encefálico infantil.	gliomas highlights platelet-derived 0.0180248 encefálico infantiles recién 0.0174306 focal brainstem gliomas 0.0175295 brainstem tumors 0.0356739 mutación h3 k27m 0.0183362 activating acvr1 mutations 0.0269847 pediatric brain 0.0219051 glioma with 0.0184685 encefálico focales recidivantes 0.0176848 Radiat Oncol Biol 0.0940294 Pediatric Brain Tumor 0.0189297 mutación h3 0.0289221 diffuse brainstem glioma 0.0359565 brainstem gliomas 0.119063 central nervous system 0.0139993 recurrent activating acvr1 0.0274852 Nat Genet 0.0675122 intrinsic brain stem 0.0150908 patients with 0.025125 radiation therapy 0.0349088 intrinsic pontine glioma 0.946885 Acta Neuropathol 0.0426011 encefálico infantiles grupo 0.0167365 Broniscer A 0.0151338 intrinsic brainstem gliomas 0.0346829	Pediatric MATCH 0.0156687 encefálico focales recién 0.0279293 Neuro Oncol 0.0299682 with newly 0.0211799 brain stem gliomas 0.0552126 encefálico infantiles recidivantes 0.0293915 pediatric patients 0.0205505 low-grade glioma 0.0256326 Pediatr Blood Cancer 0.019874 intracranial low-grade gliomas 0.0165924 report from 0.0151672 tumores dipg 0.0243332 encefálico focales resección 0.0182395 Clin Oncol 0.0362551 Oncol Biol Phys 0.0989347 Zhou T 0.0230102 Neurosurg Pediatr 0.0180743 Pediatric Oncology Group 0.0173483 newly diagnosed 0.0303637 with neurofibromatosis 0.0165895 children's oncology group 0.138637 Acta Neuropathol Commun 0.0194776 Childs Nerv Syst 0.0434615 diffuse intrinsic pontine 0.990784	CLICK HERE
1909	National Cancer Institute	Html	es	Tratamiento de la leucemia mielógena crónica (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de la leucemia mielógena crónica.	siguientes procedimientos 0.425256 células madre 0.845072 Chronic Myelogenous Leukemia 0.438357 leucemia linfoblástica aguda 0.438362 hueso compacto 0.417479 enlace drugs approved 0.436902 cromosoma filadelfia 0.526385 célula madre mieloide 0.437781 Sudores nocturnos 0.404959 células anormales.ampliar aspiración 0.417986 enlace medicamentos 0.404489 National Cancer Institute 0.403419 siguientes riesgos 0.40277	Instituto Nacional 0.405884 célula madre linfoide 0.438967 PDQ Tratamiento 0.410126 hijos.ampliar cromosoma filadelfia 0.412419 leucemia mielógena 0.99599 Physician Data Query 0.412686 laboratorio piezas 0.403757 leucemia mieloide aguda 0.437955 siguientes exámenes 0.405471 célula madre 0.512002 células sanguíneas maduras 0.448469 ósea elabora células 0.429135 siguientes sumarios 0.40998	CLICK HERE
1921	National Cancer Institute	Html	es	Tratamiento del cáncer de piel (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de piel.	almacena agua 0.377251 siguientes procedimientos 0.484494 Estadio IA 0.400496 estadio iv 0.835623 Estadio IC 0.400325 siguientes aspectos 0.39369 estadio ii 0.685519 Estadio IIIC 0.402008 estadios ia 0.349569 Estadio IIIA 0.403211 rayos x 0.363326 pulmón.ampliar cáncer 0.632928 menor cantidad 0.423989 luz solar 0.966967 Basal Cell Carcinoma 0.789488 vitamina d 0.373991 National Cancer Institute 0.332744	vitamina a 0.337818 siguientes riesgos 0.326866 pequeños carcinomas 0.336448 Instituto Nacional 0.361575 PDQ Tratamiento 0.358407 Drugs Approved 0.513635 Physician Data Query 0.424982 Cabello pelirrojo 0.519578 lápiz mide 0.408824 siguientes características 0.456672 cara.ampliar cirugía 0.345299 aspecto anormal.ampliar biopsia 0.448697 piel causa efectos 0.518422 panel derecho 0.432885 siguientes sumarios 0.432177 siguientes pruebas 0.387403	CLICK HERE
2011	National Cancer Institute	Html	es	Exámenes de detección del cáncer de pulmón (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de las pruebas utilizadas para detectar o vigilar el cáncer de pulmón.	lung cancer screening 0.491865 Berg CD 0.308884 UK Lung Cancer 0.309828 Cooperative Early Lung 0.306877 Lung Cancer Study 0.310626 lung cancer 0.996403 Reduced lung-cancer mortality 0.308509 American Cancer Society 0.314872 Sloan-Kettering Lung Study 0.306329 Extended lung 0.305748 lung-cancer screening 0.305282 Lung Screening Trial 0.34779 Preventive Services Task 0.315666 early lung cancer 0.370281 Cancer Res 0.308506 screening results 0.305543 exámenes detección 0.3124 Screening Trial 0.41076 lung-cancer mortality with 0.308638 Randomized Danish Lung 0.306065 CT screening 0.322848 Natl Cancer Inst 0.348878 small lung 0.309116 Lung Cancer Risk 0.310447 from baseline screening 0.305357	More lung 0.305626 Screening Trial with 0.311542 early stage lung 0.306471 Is curable lung 0.306471 cytologic screening 0.312546 Hocking WG 0.305973 Hopkins Lung Project 0.306129 CT screening according 0.305575 Danish Lung Cancer 0.338861 Lung Cancer Action 0.32014 randomised danish lung 0.306155 National Lung Screening 0.345051 Intern Med 0.314222 lung cancer detection 0.362796 Services Task Force 0.31539 Randomized Lung Cancer 0.310797 from semi-annual screening 0.30542 PLCO Cancer Screening 0.310194 Mayo Lung Project 0.341943 lung cancers detected 0.306094 Memorial Sloan-Kettering 0.306282 Cancer Action Project 0.310925 Lung Project revisited 0.306785 Cancer Screening Trial 0.390805	CLICK HERE
2075	National Cancer Institute	Html	es	Cánceres de cabeza y cuello	Hoja informativa acerca de los factores de riesgo, síntomas, diagnóstico, tratamiento, seguimiento y rehabilitación por los cánceres de cabeza y cuello.	Neck Cancer Epidemiology 0.358567 3rd ed 0.326841 NCI Vacunas 0.308043 American Cancer Society 0.337456 Epstein-Barr virus with 0.308914 Epstein-Barr virus 0.318034 Cancer Statistics 0.318768 Winn DM 0.308575 escamoso metastático 0.312489 case-control studies 0.308924 Cancer Institute State 0.321996 risk factors 0.312336 Brennan P 0.309874 Estados Unidos 0.32769 PubMed Abstract 0.972002 Gillison ML 0.308728 neck cancers 0.463711 Leclerc A 0.308319 patients with 0.31588 Cancer Epidemiology 0.478301 epstein-barr virus dna 0.30801 Boffetta P 0.327923 Chuang SC 0.308139 Cancer Epidemiology Consortium 0.352034 Cancer Journal 0.322016	International Journal 0.329442 Schottenfeld D 0.32536 upper aerodigestive tract 0.317554 second primary tumors 0.315336 United States 0.307873 neck squamous 0.307836 Fraumeni JF Jr 0.348613 International Head 0.313722 Nasopharyngeal Cancer 0.321339 occupational exposure 0.308922 National Cancer Institute 0.392376 Cancer Research 0.332513 Oxford University 0.322621 New York 0.321319 Yuan JM 0.308767 Epstein-Barr virus infection 0.308137 nasopharyngeal carcinoma 0.309899 international case-control study 0.316625 cáncer del nci 0.316951 Neck Surgery 0.30769 pooled analysis 0.329801 Clinical Cancer Research 0.320259 Habitual risk factors 0.308377 Cancer Biology 0.320747	CLICK HERE
15639	National Cancer Institute	Html	null	Grants	Learn about the different grants that are available, such as Research Projects Grants, SPORE Grants, career awards and cancer education grants, training grants, and others.			CLICK HERE
15642	National Cancer Institute	Html	en	Introduction to the Grants Process	Information about the NCI grants process, including recipient eligibility, the different people involved, and information about funding.	Grant section 0.330468 Grants Management Officer 0.557994 business management aspects 0.330645 Revision /Administrative Supplement 0.292103 ongoing extramural activity 0.334159 individual collaborates 0.230568 visit nci 0.417726 legally binding document 0.294148 grant type 0.376998 Application Development 0.390783 funding opportunity announcements 0.296925 particular grant program 0.476454 Research grant funds 0.454642 federal financial assistance 0.312865 scientific research projects 0.381722 additional history 0.228572 Name-Change Agreements 0.225495 cooperative agreement 0.324362 Federal funding limits 0.287544 cancer research services 0.337764 scientific aims 0.238931 recipient organizations 0.237533 NIH organizational component 0.335362 cooperative agreements 0.410646	scientific responsibility 0.224818 basic information 0.22908 Program Announcement 0.22809 clinical research 0.242867 grant application submissions 0.45483 Institutional Business Official 0.318274 grant award 0.34942 important process 0.252274 extramural scientists/clinicians 0.245811 grant application types 0.455543 recipient organization officials 0.350637 NCI Program Directors/Program 0.52301 Grants Management Specialists 0.412374 NCI Grants Management 0.594717 NCI grants process 0.906594 Program Announcements 0.289703 research organization 0.254758 Grants.gov Authorized Organizational 0.310309 cancer care delivery 0.312355 grant portfolio 0.3628 NCI grants program 0.607154 extramural program 0.270142 application process 0.236143 Recipient Institution/Organization 0.256421	CLICK HERE